PD of VAY736 in Patients With Primary Sjögren's Syndrome

NCT02149420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sjögren's Syndrome

Interventions

DRUG: VAY736
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals